European BiotechNovo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI PartnerVia News Editorial Team•Jun 25, 2026
European PharmaNovo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal UnitVia News Editorial Team•May 16, 2026